Search

Your search keyword '"Tamussino, K"' showing total 712 results
Start Over Author "Tamussino, K"
712 results on '"Tamussino, K"'

2. Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study

Author

Negri, S, Fisch, C, de Hullu, J, van Bommel, M, Simons, M, Bogaerts, J, Apperloo, M, Baiocchi, G, Bakker, J, Bart, J, van Beekhuizen, H, Bernardini, M, Boere, I, Bulten, J, Chen, L, Chrzan, A, Dorum, A, Ewing-Graham, P, Ferrero, A, Floter Radestad, A, Fruscio, R, Gaarenstroom, K, Garcia, C, Harter, P, Hoogstad-van Evert, J, de Iaco, P, Klooster, A, Kooreman, L, Jacobsen, M, Kruse, A, Kwon, J, Lawson, B, Lax, S, van Lonkhuijzen, L, Lu, K, Manchanda, R, Marchetti, C, Mccluggage, W, Mcnally, O, Mourits, M, Nicum, S, Norquist, B, Perrone, A, Piek, J, Polastro, L, Polee, M, Rabban, J, Reesink, N, de los Reyes Oliver Perez, M, Roes, E, Rychlik, A, Shih, I, Soong, T, Speiser, P, Stone, R, Tamussino, K, Tognon, G, Tuninetti, V, Valabrega, G, Vos, M, Welz, J, Zizioli, V, Hermens, R, Steenbeek, M, Negri S., Fisch C., de Hullu J. A., van Bommel M., Simons M., Bogaerts J., Apperloo M. J. A., Baiocchi G., Bakker J. L., Bart J., van Beekhuizen H. J., Bernardini M. Q., Boere I., Bulten J., Chen L. -M., Chrzan A., Dorum A., Ewing-Graham P. C., Ferrero A., Floter Radestad A., Fruscio R., Gaarenstroom K. N., Garcia C., Harter P., Hoogstad-van Evert J. S., de Iaco P., Klooster A., Kooreman L. F. S., Jacobsen M., Kruse A. -J., Kwon J. S., Lawson B. C., Lax S. F., van Lonkhuijzen L. R. C. W., Lu K. H., Manchanda R., Marchetti C., McCluggage W. G., McNally O. M., Mourits M. J. E., Nicum S., Norquist B. M., Perrone A. M., Piek J. M. J., Polastro L., Polee M. B., Rabban J. T., Reesink N., de los Reyes Oliver Perez M., Roes E. -M., Rychlik A., Shih I. -M., Soong T. R., Speiser P., Stone R. L., Tamussino K., Tognon G., Tuninetti V., Valabrega G., Vos M. C., Welz J., Zizioli V., Hermens R. P. M. G., Steenbeek M. P., Negri, S, Fisch, C, de Hullu, J, van Bommel, M, Simons, M, Bogaerts, J, Apperloo, M, Baiocchi, G, Bakker, J, Bart, J, van Beekhuizen, H, Bernardini, M, Boere, I, Bulten, J, Chen, L, Chrzan, A, Dorum, A, Ewing-Graham, P, Ferrero, A, Floter Radestad, A, Fruscio, R, Gaarenstroom, K, Garcia, C, Harter, P, Hoogstad-van Evert, J, de Iaco, P, Klooster, A, Kooreman, L, Jacobsen, M, Kruse, A, Kwon, J, Lawson, B, Lax, S, van Lonkhuijzen, L, Lu, K, Manchanda, R, Marchetti, C, Mccluggage, W, Mcnally, O, Mourits, M, Nicum, S, Norquist, B, Perrone, A, Piek, J, Polastro, L, Polee, M, Rabban, J, Reesink, N, de los Reyes Oliver Perez, M, Roes, E, Rychlik, A, Shih, I, Soong, T, Speiser, P, Stone, R, Tamussino, K, Tognon, G, Tuninetti, V, Valabrega, G, Vos, M, Welz, J, Zizioli, V, Hermens, R, Steenbeek, M, Negri S., Fisch C., de Hullu J. A., van Bommel M., Simons M., Bogaerts J., Apperloo M. J. A., Baiocchi G., Bakker J. L., Bart J., van Beekhuizen H. J., Bernardini M. Q., Boere I., Bulten J., Chen L. -M., Chrzan A., Dorum A., Ewing-Graham P. C., Ferrero A., Floter Radestad A., Fruscio R., Gaarenstroom K. N., Garcia C., Harter P., Hoogstad-van Evert J. S., de Iaco P., Klooster A., Kooreman L. F. S., Jacobsen M., Kruse A. -J., Kwon J. S., Lawson B. C., Lax S. F., van Lonkhuijzen L. R. C. W., Lu K. H., Manchanda R., Marchetti C., McCluggage W. G., McNally O. M., Mourits M. J. E., Nicum S., Norquist B. M., Perrone A. M., Piek J. M. J., Polastro L., Polee M. B., Rabban J. T., Reesink N., de los Reyes Oliver Perez M., Roes E. -M., Rychlik A., Shih I. -M., Soong T. R., Speiser P., Stone R. L., Tamussino K., Tognon G., Tuninetti V., Valabrega G., Vos M. C., Welz J., Zizioli V., Hermens R. P. M. G., and Steenbeek M. P.

Abstract

Objective: A Serous Tubal Intraepithelial Carcinoma (STIC) without concomitant invasive carcinoma is occasionally identified and associated with a high risk of subsequent peritoneal carcinomatosis. Management needs optimisation. This study explores professionals' opinions and clinical practices regarding the diagnosis, counselling, treatment and follow-up of isolated STIC to facilitate clinical decision making and optimise the direction of future research. A secondary aim is to assess international clinical guidelines. Design: Focus group study. Setting: Four online sessions. Population: International panel (n = 12 countries) of gynaecologists, gynaecologic oncologists, pathologists and medical oncologists (n = 49). Methods: A semi-structured interview guide was used. Two independent researchers analysed transcripts by open and axial coding. Results were organised in domains. Relevant (inter)national guidelines were screened for recommendations regarding isolated STIC. Main Outcome Measures: Professionals' opinions and clinical practices regarding isolated STIC management. Results: Regarding pathology, most professionals identified the SEE-FIM protocol as standard of care for high-risk patients, whereas variation exists in the histopathological examination of fallopian tubes in the general population. Confirmation of STIC diagnosis by a specialised pathologist was recommended. Regarding work-up and follow-up after STIC diagnosis, there was variety and discordance. Data on outcomes is limited. As for treatment, chemotherapy and PARP inhibitors were not recommended by most. Eleven guidelines provided limited recommendations. Conclusions: We identified recommendations and highlighted knowledge gaps in the diagnosis and management of isolated STIC. Moreover, recommendations in clinical guidelines are limited. There is an agreed need for international collaboration for the prospective registration of isolated STIC.

Published
2024

3. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

Author

Levenback, C.F., Hermans, R.H., Bouda, J., Sharma, A., Luesley, D., Ellis, P., Cruickshank, D.J., Duncan, T.J., Kieser, K., Palle, C., Spirtos, N.M., O'Malley, D.M., Leitao, M.M., Geller, M., Dhar, K., Asher, V., Tobias, D.H., Borgfeldt, C., Lea, J.S., Lood, M., Bailey, J., Eyjolfsdottir, B., Attard-Montalto, S., Tewari, K.S., Persson, P., Manchanda, R., Jensen, P., Van Le, L., Van der Kolk, W.L., Van der Zee, A.G.J., Slomovitz, B.M., Baldwin, P.J.W., Van Doorn, H.C., De Hullu, J.A., Van der Velden, J., Gaarenstroom, K.N., Slangen, B.F.M., Kjolhede, P., Brännström, M., Vergote, I., Holland, C.M., Coleman, R., Van Dorst, E.B.L., Van Driel, W.J., Nunns, D., Widschwendter, M., Nugent, D., DiSilvestro, P.A., Mannel, R.S., Tjiong, M.Y., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I.B., Monk, B.J., Zanagnolo, V., Tamussino, K., and Oonk, M.H.M.

Published
2022
Full Text
View/download PDF

6. The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the German “Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)”, the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology

Author

Dueckelmann, A. M., Fink, D., Harter, P., Heinzelmann, V., Marth, C., Mueller, M., Reinthaller, A., Tamussino, K., Wimberger, P., and Sehouli, J.

Published
2018
Full Text
View/download PDF

11. SUCCOR study. An international european cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009, <4 cm) cervical cancer operated in 2013-2014

Author

Chiva, L, Zanagnolo, V, Kucukmetin, A, Chakalova, G, Raspagliesi, F, Narducci, F, Toptas, T, Meydanli, M, Fagotti, A, Cibula, D, Wydra, D, Póka, R, Jach, R, Tavares, M, Tamussino, K, Haidopoulos, D, Ponce, J, Berlev, I, Roldán, F, Domingo, S, Zapardiel, I, Goncalves, E, Malzoni, M, Arencibia, O, Kukk, K, Haller, H, Vorgias, G, Ghezzi, F, Guyon, F, Herrero, S, Haesen, J, Feron, J G, Minguez, J, Chacon, E, Vazquez, D, Castellanos, T, Arevalo, J, Calvo, Martin N, and Alcazar, J L

Published
2019
Full Text
View/download PDF

12. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

Author

Kolk, W.L. van der, Zee, A.G.J. van der, Slomovitz, B.M., Baldwin, P.J.W., Doorn, H.C. van, Hullu, J.A. de, Velden, J. van der, Gaarenstroom, K.N., Slangen, B.F.M., Kjolhede, P., Brannstrom, M., Vergote, I., Holland, C.M., Coleman, R., Dorst, E.B.L. van, Driel, W.J. van, Nunns, D., Widschwendter, M., Nugent, D., DiSilvestro, P.A., Mannel, R.S., Tjiong, M.Y., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I.B., Monk, B.J., Zanagnolo, V., Tamussino, K., Oonk, M.H.M., Levenback, C.F., Hermans, R.H., Bouda, J., Sharma, A., Luesley, D., Ellis, P., Cruickshank, D.J., Duncan, T.J., Kieser, K., Palle, C., Spirtos, N.M., O'Malley, D.M., Leitao, M.M., Geller, M., Dhar, K., Asher, V., Tobias, D.H., Borgfeldt, C., Lea, J.S., Lood, M., Bailey, J., Eyjolfsdottir, B., Attard-Montalto, S., Tewari, K.S., Persson, P., Manchanda, R., Jensen, P., L. van le, GROINSS-V I II Participants, Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Targeted Gynaecologic Oncology (TARGON), Cancer Center Amsterdam, Obstetrics and Gynaecology, CCA - Cancer Treatment and Quality of Life, and Gynecological Oncology

Subjects
Lymphadenopathy, CANCER-PATIENTS, Groin, Humans, Science & Technology, Vulvar Neoplasms, Vulvar cancer, Radiotherapy, Sentinel Lymph Node Biopsy, Kirurgi, Obstetrics and Gynecology, Obstetrics & Gynecology, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Oncology, Sentinel lymph node, Inguinofemoral lymphadenectomy, Lymph node metastases, Lymphatic Metastasis, Carcinoma, Squamous Cell, Lymph Node Excision, Surgery, Female, Lymph Nodes, Neoplasm Recurrence, Local, Life Sciences & Biomedicine
Abstract

Objective. Optimal management of the contralateral groin in patients with early-stage vulvar squamous cell carcinoma (VSCC) and a metastatic unilateral inguinal sentinel lymph node (SN) is unclear. We analyzed patients who participated in GROINSS-V I or II to determine whether treatment of the contralateral groin can safely be omitted in patients with a unilateral metastatic SN.Methods. We selected the patients with a unilateral metastatic SN from the GROINSS-V I and II databases. We determined the incidence of contralateral additional non-SN metastases in patients with unilateral SN-metastasis who underwent bilateral inguinofemoral lymphadenectomy (IFL). In those who underwent only ipsilateral groin treatment or no further treatment, we determined the incidence of contralateral groin recurrences during follow-up.Results. Of 1912 patients with early-stage VSCC, 366 had a unilateral metastatic SN. Subsequently, 244 had an IFL or no treatment of the contralateral groin. In seven patients (7/244; 2.9% [95% CI: 1.4%-5.8%]) disease was di-agnosed in the contralateral groin: five had contralateral non-SN metastasis at IFL and two developed an isolated contralateral groin recurrence after no further treatment. Five of them had a primary tumor >= 30 mm. Bilateral ra-diotherapy was administered in 122 patients, of whom one (1/122; 0.8% [95% CI: 0.1%-4.5%]) had a contralateral groin recurrence.Conclusion. The risk of contralateral lymph node metastases in patients with early-stage VSCC and a unilateral metastatic SN is low. It appears safe to limit groin treatment to unilateral IFL or inguinofemoral radiotherapy in these cases.(c) 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/). On behalf of all GROINSS-V I and II participants: C.F. Levenback, R.H. Hermans, J. Bouda, A. Sharma, D. Luesley, P. Ellis, D.J. Cruickshank, T.J. Duncan, K. Kieser,C. Palle, N.M. Spirtos, D.M. O'Malley, M.M. Leitao, M. Geller, K. Dhar, V. Asher, D.H. Tobias, C. Borgfeldt, J.S. Lea,M. Lood, J. Bailey, B. Eyjolfsdottir, S. Attard-Montalto, K.S. Tewari, P. Persson, R. Manchanda, P. Jensen, L. Van Le

Published
2022
Full Text
View/download PDF

15. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

Author

Van der Kolk, W.L., primary, Van der Zee, A.G.J., additional, Slomovitz, B.M., additional, Baldwin, P.J.W., additional, Van Doorn, H.C., additional, De Hullu, J.A., additional, Van der Velden, J., additional, Gaarenstroom, K.N., additional, Slangen, B.F.M., additional, Kjolhede, P., additional, Brännström, M., additional, Vergote, I., additional, Holland, C.M., additional, Coleman, R., additional, Van Dorst, E.B.L., additional, Van Driel, W.J., additional, Nunns, D., additional, Widschwendter, M., additional, Nugent, D., additional, DiSilvestro, P.A., additional, Mannel, R.S., additional, Tjiong, M.Y., additional, Boll, D., additional, Cibula, D., additional, Covens, A., additional, Provencher, D., additional, Runnebaum, I.B., additional, Monk, B.J., additional, Zanagnolo, V., additional, Tamussino, K., additional, Oonk, M.H.M., additional, Levenback, C.F., additional, Hermans, R.H., additional, Bouda, J., additional, Sharma, A., additional, Luesley, D., additional, Ellis, P., additional, Cruickshank, D.J., additional, Duncan, T.J., additional, Kieser, K., additional, Palle, C., additional, Spirtos, N.M., additional, O'Malley, D.M., additional, Leitao, M.M., additional, Geller, M., additional, Dhar, K., additional, Asher, V., additional, Tobias, D.H., additional, Borgfeldt, C., additional, Lea, J.S., additional, Lood, M., additional, Bailey, J., additional, Eyjolfsdottir, B., additional, Attard-Montalto, S., additional, Tewari, K.S., additional, Persson, P., additional, Manchanda, R., additional, Jensen, P., additional, and Van Le, L., additional

Published
2022
Full Text
View/download PDF

17. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

Author

Cibula, D, Planchamp, F, Fischerova, D, Fotopoulou, C, Kohler, C, Landoni, F, Mathevet, P, Naik, R, Ponce, J, Raspagliesi, F, Rodolakis, A, Tamussino, K, Taskiran, C, Vergote, I, Wimberger, P, Zahl Eriksson, A, Querleu, D, Cibula D., Planchamp F., Fischerova D., Fotopoulou C., Kohler C., Landoni F., Mathevet P., Naik R., Ponce J., Raspagliesi F., Rodolakis A., Tamussino K., Taskiran C., Vergote I., Wimberger P., Zahl Eriksson A. G., Querleu D., Cibula, D, Planchamp, F, Fischerova, D, Fotopoulou, C, Kohler, C, Landoni, F, Mathevet, P, Naik, R, Ponce, J, Raspagliesi, F, Rodolakis, A, Tamussino, K, Taskiran, C, Vergote, I, Wimberger, P, Zahl Eriksson, A, Querleu, D, Cibula D., Planchamp F., Fischerova D., Fotopoulou C., Kohler C., Landoni F., Mathevet P., Naik R., Ponce J., Raspagliesi F., Rodolakis A., Tamussino K., Taskiran C., Vergote I., Wimberger P., Zahl Eriksson A. G., and Querleu D.

Abstract

Background Optimizing and ensuring the quality of surgical care is essential to improve the management and outcome of patients with cervical cancer. To develop a list of quality indicators for surgical treatment of cervical cancer that can be used to audit and improve clinical practice. Methods Quality indicators were developed using a four-step evaluation process that included a systematic literature search to identify potential quality indicators, in-person meetings of an ad hoc group of international experts, an internal validation process, and external review by a large panel of European clinicians and patient representatives. Results Fifteen structural, process, and outcome indicators were selected. Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are also detailed to define how the indicator will be measured in practice. Each indicator has a target which gives practitioners and health administrators a quantitative basis for improving care and organizational processes. Discussion Implementation of institutional quality assurance programs can improve quality of care, even in high-volume centers. This set of quality indicators from the European Society of Gynaecological Cancer may be a major instrument to improve the quality of surgical treatment of cervical cancer

Published
2020

18. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

Author

Van der Kolk, W. L., Van der Zee, A. G. J., Slomovitz, B. M., Baldwin, P. J. W., Van Doorn, H. C., De Hullu, J. A., Van der Velden, J., Gaarenstroom, K. N., Slangen, B. F. M., Kjölhede, Preben, Brännstrom, M., Vergote, I, Holland, C. M., Coleman, R., Van Dorst, E. B. L., Van Driel, W. J., Nunns, D., Widschwendter, M., Nugent, D., DiSilvestro, P. A., Mannel, R. S., Tjiong, M. Y., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I. B., Monk, B. J., Zanagnolo, V, Tamussino, K., Oonk, M. H. M., Van der Kolk, W. L., Van der Zee, A. G. J., Slomovitz, B. M., Baldwin, P. J. W., Van Doorn, H. C., De Hullu, J. A., Van der Velden, J., Gaarenstroom, K. N., Slangen, B. F. M., Kjölhede, Preben, Brännstrom, M., Vergote, I, Holland, C. M., Coleman, R., Van Dorst, E. B. L., Van Driel, W. J., Nunns, D., Widschwendter, M., Nugent, D., DiSilvestro, P. A., Mannel, R. S., Tjiong, M. Y., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I. B., Monk, B. J., Zanagnolo, V, Tamussino, K., and Oonk, M. H. M.

Abstract

Objective. Optimal management of the contralateral groin in patients with early-stage vulvar squamous cell carcinoma (VSCC) and a metastatic unilateral inguinal sentinel lymph node (SN) is unclear. We analyzed patients who participated in GROINSS-V I or II to determine whether treatment of the contralateral groin can safely be omitted in patients with a unilateral metastatic SN.Methods. We selected the patients with a unilateral metastatic SN from the GROINSS-V I and II databases. We determined the incidence of contralateral additional non-SN metastases in patients with unilateral SN-metastasis who underwent bilateral inguinofemoral lymphadenectomy (IFL). In those who underwent only ipsilateral groin treatment or no further treatment, we determined the incidence of contralateral groin recurrences during follow-up.Results. Of 1912 patients with early-stage VSCC, 366 had a unilateral metastatic SN. Subsequently, 244 had an IFL or no treatment of the contralateral groin. In seven patients (7/244; 2.9% [95% CI: 1.4%-5.8%]) disease was di-agnosed in the contralateral groin: five had contralateral non-SN metastasis at IFL and two developed an isolated contralateral groin recurrence after no further treatment. Five of them had a primary tumor >= 30 mm. Bilateral ra-diotherapy was administered in 122 patients, of whom one (1/122; 0.8% [95% CI: 0.1%-4.5%]) had a contralateral groin recurrence.Conclusion. The risk of contralateral lymph node metastases in patients with early-stage VSCC and a unilateral metastatic SN is low. It appears safe to limit groin treatment to unilateral IFL or inguinofemoral radiotherapy in these cases.(c) 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/)., On behalf of all GROINSS-V I and II participants: C.F. Levenback, R.H. Hermans, J. Bouda, A. Sharma, D. Luesley, P. Ellis, D.J. Cruickshank, T.J. Duncan, K. Kieser,C. Palle, N.M. Spirtos, D.M. O'Malley, M.M. Leitao, M. Geller, K. Dhar, V. Asher, D.H. Tobias, C. Borgfeldt, J.S. Lea,M. Lood, J. Bailey, B. Eyjolfsdottir, S. Attard-Montalto, K.S. Tewari, P. Persson, R. Manchanda, P. Jensen, L. Van Le

Published
2022
Full Text
View/download PDF

19. Urogynäkologische Funktionsdiagnostik

Author

Kölbl, H., Kölle, D., Peschers, U. M., Leib, B., Dimpfl, Th., Hanzal, E., Anthuber, C., Lienemann, A., Baron, A., Tamussino, K., Grischke, E. M., Maleika, A., Bastert, G., Berg, Dietrich, editor, Diedrich, Klaus, editor, and Rauskolb, Rüdiger, editor

Published
2000
Full Text
View/download PDF

23. ERAS bei der Sectio: Wo stehen wir in Österreich?

Author

Hochstätter, R, additional, Schütz, A-M, additional, Taumberger, N, additional, Bornemann-Cimenti, H, additional, Oppelt, P, additional, Fazelnia, C, additional, Petricevic, L, additional, Tsibulak, I, additional, Batiduan, L-M, additional, Tomasch, G, additional, Weiss, E-C, additional, Tamussino, K, additional, Metnitz, P, additional, Schöll, W, additional, and Fluhr, Herbert, additional

Published
2022
Full Text
View/download PDF

34. Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland

Author

Dueckelmann, A. M., Fink, D., Harter, P., Heinzelmann, V., Marth, C., Mueller, M., Reinthaller, A., Tamussino, K., Wimberger, P., and Sehouli, J.

Published
2018
Full Text
View/download PDF

37. Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

Author

Oonk, M.H., Slomovitz, B., Baldwin, P.J., Doorn, H.C. van, Velden, J. van der, Hullu, J.A. de, Gaarenstroom, K.N., Slangen, B.F.M., Vergote, I., Brännström, M., Dorst, E.B.L. van, Driel, W.J. van, Hermans, R.H., Nunns, D., Widschwendter, M., Nugent, D., Holland, C.M., Sharma, A., DiSilvestro, P.A., Mannel, R., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I.B., Luesley, D., Ellis, P., Duncan, T.J., Tjiong, M.Y., Cruickshank, D.J., Kjølhede, P., Levenback, C.F., Bouda, J., Kieser, K.E., Palle, C., Spirtos, N.M., O'Malley, D.M., Leitao, M.M., Geller, M.A., Dhar, K., Asher, V., Tamussino, K., Tobias, D.H., Borgfeldt, C., Lea, J.S., Bailey, J., Lood, M., Eyjolfsdottir, B., Attard-Montalto, S., Tewari, K.S., Manchanda, R., Jensen, P.T., Persson, P., Le, L, Putter, H., Bock, G.H. de, Monk, B.J., Creutzberg, C.L., Zee, A.G. van der, Oonk, M.H., Slomovitz, B., Baldwin, P.J., Doorn, H.C. van, Velden, J. van der, Hullu, J.A. de, Gaarenstroom, K.N., Slangen, B.F.M., Vergote, I., Brännström, M., Dorst, E.B.L. van, Driel, W.J. van, Hermans, R.H., Nunns, D., Widschwendter, M., Nugent, D., Holland, C.M., Sharma, A., DiSilvestro, P.A., Mannel, R., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I.B., Luesley, D., Ellis, P., Duncan, T.J., Tjiong, M.Y., Cruickshank, D.J., Kjølhede, P., Levenback, C.F., Bouda, J., Kieser, K.E., Palle, C., Spirtos, N.M., O'Malley, D.M., Leitao, M.M., Geller, M.A., Dhar, K., Asher, V., Tamussino, K., Tobias, D.H., Borgfeldt, C., Lea, J.S., Bailey, J., Lood, M., Eyjolfsdottir, B., Attard-Montalto, S., Tewari, K.S., Manchanda, R., Jensen, P.T., Persson, P., Le, L, Putter, H., Bock, G.H. de, Monk, B.J., Creutzberg, C.L., and Zee, A.G. van der

Abstract

Item does not contain fulltext, PURPOSE: The Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V)-II investigated whether inguinofemoral radiotherapy is a safe alternative to inguinofemoral lymphadenectomy (IFL) in vulvar cancer patients with a metastatic sentinel node (SN). METHODS: GROINSS-V-II was a prospective multicenter phase-II single-arm treatment trial, including patients with early-stage vulvar cancer (diameter < 4 cm) without signs of lymph node involvement at imaging, who had primary surgical treatment (local excision with SN biopsy). Where the SN was involved (metastasis of any size), inguinofemoral radiotherapy was given (50 Gy). The primary end point was isolated groin recurrence rate at 24 months. Stopping rules were defined for the occurrence of groin recurrences. RESULTS: From December 2005 until October 2016, 1,535 eligible patients were registered. The SN showed metastasis in 322 (21.0%) patients. In June 2010, with 91 SN-positive patients included, the stopping rule was activated because the isolated groin recurrence rate in this group went above our predefined threshold. Among 10 patients with an isolated groin recurrence, nine had SN metastases > 2 mm and/or extracapsular spread. The protocol was amended so that those with SN macrometastases (> 2 mm) underwent standard of care (IFL), whereas patients with SN micrometastases (≤ 2 mm) continued to receive inguinofemoral radiotherapy. Among 160 patients with SN micrometastases, 126 received inguinofemoral radiotherapy, with an ipsilateral isolated groin recurrence rate at 2 years of 1.6%. Among 162 patients with SN macrometastases, the isolated groin recurrence rate at 2 years was 22% in those who underwent radiotherapy, and 6.9% in those who underwent IFL (P = .011). Treatment-related morbidity after radiotherapy was less frequent compared with IFL. CONCLUSION: Inguinofemoral radiotherapy is a safe alternative for IFL in patients with SN micrometastases, with minimal morbidity. For patients with SN macr

Published
2021

45. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer

Author

Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Mccluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., McCluggage W. G., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., Raspollini M. R., Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Mccluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., McCluggage W. G., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., and Raspollini M. R.

Abstract

Background:: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer. Objective:: The European Society of Gynecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide. Methods:: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives. Results:: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.

Published
2018

46. Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (Virchows Archiv, (2018), 472, 6, (937-938), 10.1007/s00428-018-2380-7)

Author

Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Mccluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., McCluggage W. G., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., Raspollini M. R., Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Mccluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., McCluggage W. G., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., and Raspollini M. R.

Abstract

Regrettably, the author metadata used for the previous correction (doi: https://doi.org/10.1007/s00428-018-2380-7) contained an error in the tagging of W. Glenn McCluggage’s name; this has been corrected. No further adjustments have been made to the Correction, or the original Guideline paper (doi: https://doi.org/10.1007/s00428-018-2362-9).

Published
2018

47. Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (Virchows Archiv, (2018), 472, 6, (937-938), 10.1007/s00428-018-2380-7)

Author

Cibula D., Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Mccluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., McCluggage W. G., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., Raspollini M. R., Cibula D., Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Mccluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., McCluggage W. G., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., and Raspollini M. R.

Abstract

Regrettably, the author metadata used for the previous correction (doi: https://doi.org/10.1007/s00428-018-2380-7) contained an error in the tagging of W. Glenn McCluggage’s name; this has been corrected. No further adjustments have been made to the Correction, or the original Guideline paper (doi: https://doi.org/10.1007/s00428-018-2362-9).

Published
2018

48. Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (Virchows Archiv, (2018), 472, 6, (919-936), 10.1007/s00428-018-2362-9)

Author

Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Glenn McCluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., Glenn McCluggage W., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., Raspollini M. R., Cibula, D, Potter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie-Meder, C, Kohler, C, Landoni, F, Lax, S, Lindegaard, J, Mahantshetty, U, Mathevet, P, Glenn McCluggage, W, Mccormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Raspagliesi, F, Rodolakis, A, Tamussino, K, Wimberger, P, Raspollini, M, Cibula D., Potter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie-Meder C., Kohler C., Landoni F., Lax S., Lindegaard J. C., Mahantshetty U., Mathevet P., Glenn McCluggage W., McCormack M., Naik R., Nout R., Pignata S., Ponce J., Querleu D., Raspagliesi F., Rodolakis A., Tamussino K., Wimberger P., and Raspollini M. R.

Abstract

Two corrections were made to the above publication following its original online publication on 4th May 2018.

Published
2018

49. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

Author

Cibula, D. Planchamp, F. Fischerova, D. Fotopoulou, C. Kohler, C. Landoni, F. Mathevet, P. Naik, R. Ponce, J. Raspagliesi, F. Rodolakis, A. Tamussino, K. Taskiran, C. Vergote, I. Wimberger, P. Zahl Eriksson, A.G. Querleu, D.

Abstract

Background Optimizing and ensuring the quality of surgical care is essential to improve the management and outcome of patients with cervical cancer. To develop a list of quality indicators for surgical treatment of cervical cancer that can be used to audit and improve clinical practice. Methods Quality indicators were developed using a four-step evaluation process that included a systematic literature search to identify potential quality indicators, in-person meetings of an ad hoc group of international experts, an internal validation process, and external review by a large panel of European clinicians and patient representatives. Results Fifteen structural, process, and outcome indicators were selected. Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are also detailed to define how the indicator will be measured in practice. Each indicator has a target which gives practitioners and health administrators a quantitative basis for improving care and organizational processes. Discussion Implementation of institutional quality assurance programs can improve quality of care, even in high-volume centers. This set of quality indicators from the European Society of Gynaecological Cancer may be a major instrument to improve the quality of surgical treatment of cervical cancer. © IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results